Maria D Ribadeneira

Maria D Ribadeneira

UNVERIFIED PROFILE

Are you Maria D Ribadeneira?   Register this Author

Register author
Maria D Ribadeneira

Maria D Ribadeneira

Publications by authors named "Maria D Ribadeneira"

Are you Maria D Ribadeneira?   Register this Author

10Publications

223Reads

30Profile Views

A strategy to reduce biliary clearance in early drug discovery.

J Pharmacol Toxicol Methods 2013 Nov-Dec;68(3):346-8. Epub 2013 Mar 19.

Department of Biological Sciences, Boehringer-Ingelheim (Canada) Ltd., Research and Development, 2100 Cunard Street, Laval, Québec H7S 2G5, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vascn.2013.03.003DOI Listing
September 2014

A membrane vesicle-based assay to enable prediction of human biliary excretion.

Xenobiotica 2013 Oct 12;43(10):915-9. Epub 2013 Feb 12.

Biological Sciences, Boehringer Ingelheim (Canada) Ltd , Laval, Québec , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00498254.2013.769649DOI Listing
October 2013

Assessment of CYP3A-mediated drug-drug interaction potential for victim drugs using an in vivo rat model.

Biopharm Drug Dispos 2013 Oct 14;34(7):396-401. Epub 2013 Aug 14.

Biological Sciences, Boehringer-Ingelheim (Canada) Ltd, 2100 Cunard Street, Laval, Québec, Canada, H7S 2G5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdd.1855DOI Listing
October 2013

A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data.

Xenobiotica 2013 Jul 17;43(7):592-7. Epub 2012 Dec 17.

Department of Biological Sciences, Boehringer Ingelheim (Canada) Ltd., Laval, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00498254.2012.751141DOI Listing
July 2013